Clinical Study:Concurrent Interventional Cisplatin Ieucovorin Fluorouracil Hydroxy Camptothecin Chemotherapy Plus Radiotherapy in Patients with Ⅳ Stage Middle-lower Section Esophageal Cancer
- VernacularTitle:介入化疗加放射治疗晚期中下段食管癌的临床研究
- Author:
Tongli JI
;
Yiqing WANG
;
Jie MIN
;
Gang LI
- Publication Type:Journal Article
- Keywords:
magligant tumour;
esophageal cancer,Ⅳ stage middle-lower section;
interventional therapy;
chemotherapy
- From:
Journal of Practical Radiology
2001;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy of concurrent interventional cisplatin,leucovorin,fluorouracil,hydroxy camptothecin chemotherapy plus radiotherapy in patients with Ⅳ stage middle-lower section esophageal cancer.Methods The subjects were all the patients with Ⅳ stage middle-lower section esophageal cancer.Among of them,42 patients,via artery,had been enrolled for concurrent interventional cisplatin,leucovorin,fluorouracil,hydroxy camptothecin chemotherapy plus radiotherapy.40 patients were given irradiation.Results The incidence rate of Ⅰ grade esophageal X-ray in the former group was 57.1%,and that in the later group was 25.0%,and the parameters had significant difference(?0.05).Conclusion Concurrent interventional cisplatin,leucovorin,fluorouracil,hydroxy camptothecin chemotherapy plus radiotherapy may be attributed to progression of Ⅳ stage middle-lower section esophageal cancer.
